Source: Fortune
Summary
The US leads the world in biopharmaceutical innovation, with American companies driving 55% of global R&D and producing more new medicines than any other country. The US is also at the forefront of healthcare innovation, with breakthroughs in cardiovascular care, cancer treatment, and artificial intelligence. However, ensuring access and affordability is crucial to making these innovations effective. The US has a unique ability to bring together institutions, manufacturing strength, and innovation ecosystems to deliver breakthroughs at scale.
Our Reading
The numbers tell one story.
American companies are driving 55% of global R&D, and the US is producing more new medicines than any other country. Johnson & Johnson is committing more than $55 billion to expand US R&D, manufacturing, and technology. The US is also leading in AI, which is transforming how scientists discover medicines and design clinical trials.
Breakthroughs are not just about discovery, but about how early and effectively we put those discoveries to work.
Author: Evan Null
